Vaccines against avian reoviruses
AssigneeBiomune Company
InventorsKristi Mae Dorsey, Brianna Ford, Christopher Luther, John Knox Rosenberger
Life of this patent
Estimating the term…
Abstract
The present invention relates to vaccine and composition comprising at least one antigenic material derived from an avian reovirus and an adjuvant comprising a lipophile and a polymer of acrylic or methacrylic acid and uses thereof for vaccinating avian against reoviruses.
Claims16
A vaccine comprising at least one antigenic material derived from an avian reovirus selected from avian reovirus designated strain S1, a sample of which is deposited at the ATCC under accession number PTA-125155 (S1), avian reovirus designated strain S2, a sample of which is deposited at the ATCC under accession number PTA-125157 (S2), avian reovirus designated strain S3, a sample of which is deposited at the ATCC under accession number PTA-125156 (S3), or any derivative thereof and an adjuvant comprising a lipophile and a polymer of acrylic or methacrylic acid.
A vaccine comprising at least one antigenic material derived from an avian reovirus selected from avian reovirus designated strain S1, a sample of which is deposited at the ATCC under accession number PTA-125155 (S1), avian reovirus designated strain S2, a sample of which is deposited at the ATCC under accession number PTA-125157 (S2), avian reovirus designated strain S3, a sample of which is deposited at the ATCC under accession number PTA-125156 (S3), and an adjuvant.
A process for preparing a vaccine comprising at least one antigenic material derived from an avian reovirus selected from avian reovirus designated strain S1, a sample of which is deposited at the ATCC under accession number PTA-125155 (S1), avian reovirus designated strain S2, a sample of which is deposited at the ATCC under accession number PTA-125157 (S2), avian reovirus designated strain S3, a sample of which is deposited at the ATCC under accession number PTA-125156 (S3), and an adjuvant, comprising
- preparing the at least one antigenic material;
- and
- adding an adjuvant comprising a lipophile and a polymer of acrylic or methacrylic acid.
Dependencies are inferred from the claim text.